NIH-funded research NIH-funded research

Improving colorectal cancer screening for diabetes patients in community health centers

Official title: Optimizing Colorectal Cancer Screening among Patients with Diabetes in Safety-Net Primary Care Settings: Targeting Implementation Approaches

Funded at Rutgers Biomedical and Health Sciences · NIH-10904675 · Data updated 2026-11-12

This study is looking at how to make colorectal cancer screening easier and more effective for people with diabetes, especially those in low-income communities, so everyone can get the preventive care they need, no matter their background.

More Diabetes research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startJanuary 1, 2021
Project endMay 31, 2026
Funding year2024
Award (this year)$249,000
NIH project number5R00CA256043-05
Project IDNIH-10904675 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with diabetes, particularly those who are Non-Hispanic Black or Hispanic, and who receive care in federally qualified health centers.

Less likely to help

Patients without diabetes or those who do not receive care in safety-net primary care settings may not benefit from this research.

What this research studies

This research focuses on enhancing colorectal cancer screening for patients with diabetes, particularly in federally qualified health centers that serve low-income and minority populations. It aims to identify barriers to effective screening and develop tailored strategies to improve access and utilization of screening tests. By examining differences in screening practices among various racial and ethnic groups, the study seeks to ensure that all patients receive appropriate preventive care. The approach includes community engagement and data-driven assessments to inform implementation strategies.

Why it matters

Potential benefit: If successful, this research could lead to increased colorectal cancer screening rates among diabetes patients, ultimately reducing cancer mortality in this high-risk group.

How similar studies have gone: Previous research has shown that targeted implementation strategies can effectively improve cancer screening rates in underserved populations, indicating potential for success in this approach.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: O'malley, Denalee M. — Rutgers Biomedical and Health Sciences
  • Study coordinator: O'malley, Denalee M.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.